Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 0.00 (0.00%)

Bid:

13,100.00

Ask:

15,000.00

Spread: 1,900.00 (14.504%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

LONDON MARKET MIDDAY: Stocks down but eurozone GDP beats forecasts

(Alliance News) - Stock prices in London were lower midday on Friday, as investors remain nervous despite the latest pause on certain US tariffs.

AstraZeneca finds Imfinzi improves survival rates for gastric cancers

(Alliance News) - AstraZeneca PLC on Friday said its Imfinzi treatment has demonstrated statistically significant results in a trial testing survival ...

AstraZeneca hails trial results for imfinzi on gastric cancer

(Sharecast News) - AstraZeneca said its Imfinzi drug when used with chemotherapy had shown "statistically significant and clinically meaningful improv...

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval

(Alliance News) - AstraZeneca PLC on Monday said its lung cancer drug Imfinzi has been recommended for approval in the EU.

LONDON BRIEFING: FTSE 100 up ahead of UK and US PMI readings

(Alliance News) - Stocks were called higher on Monday morning as investors digest news of greater-than-expected acceleration in China's manufacturing ...

AstraZeneca's Imfinzi gets recommended for fresh EU approval

(Sharecast News) - AstraZeneca announced on Monday that Imfinzi, or durvalumab, has been recommended for approval in the European Union for adults wit...

AstraZeneca, Amgen drug shows positive results in nasal polyps trials

(Alliance News) - An asthma drug has shown positive results when used to treat nasal polyps, researchers have said.

AstraZeneca breast cancer therapy wins recommendation for EU approval

(Alliance News) - AstraZeneca PLC on Friday said its breast cancer therapy, Enhertu, which is being developed jointly with Tokyo-based pharmaceutical ...